|
2025-02-25 |
2025-02-21 |
GV
Geplanter Verkauf
|
Morrell Martha
CHIEF MEDICAL OFFICER
Führungsperson
|
78.334
-48.9%
13,72
1.074.844 USD
|
78.334
-48.9%
|
13,72
|
1.074.844 USD
|
|
|
2025-02-20 |
2025-02-20 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
5.270.845
-100.0%
9,40
49.545.943 USD
|
5.270.845
-100.0%
|
9,40
|
49.545.943 USD
|
|
|
2025-01-31 |
2025-01-30 |
GV
Geplanter Verkauf
|
Morrell Martha
CHIEF MEDICAL OFFICER
Führungsperson
|
200
-0.2%
15,00
3.000 USD
|
200
-0.2%
|
15,00
|
3.000 USD
|
|
|
2025-01-31 |
2025-01-29 |
GV
Geplanter Verkauf
|
Morrell Martha
CHIEF MEDICAL OFFICER
Führungsperson
|
100
-0.1%
15,00
1.500 USD
|
100
-0.1%
|
15,00
|
1.500 USD
|
|
|
2025-01-28 |
2025-01-24 |
GV
Geplanter Verkauf
|
Morrell Martha
CHIEF MEDICAL OFFICER
Führungsperson
|
3.200
-3.5%
15,01
48.032 USD
|
3.200
-3.5%
|
15,01
|
48.032 USD
|
|
|
2024-10-28 |
2024-10-25 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
223.991
-4.1%
5,45
1.221.042 USD
|
223.991
-4.1%
|
5,45
|
1.221.042 USD
|
|
|
2024-10-28 |
2024-10-23 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
147
-0.0%
6,02
885 USD
|
147
-0.0%
|
6,02
|
885 USD
|
|
|
2024-10-24 |
2024-10-22 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
4.082
-0.1%
6,09
24.853 USD
|
4.082
-0.1%
|
6,09
|
24.853 USD
|
|
|
2024-10-22 |
2024-10-21 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
3.720
-0.1%
6,10
22.679 USD
|
3.720
-0.1%
|
6,10
|
22.679 USD
|
|
|
2024-10-22 |
2024-10-18 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
4.878
-0.1%
6,29
30.692 USD
|
4.878
-0.1%
|
6,29
|
30.692 USD
|
|
|
2024-10-18 |
2024-10-17 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
3.294
-0.1%
6,28
20.686 USD
|
3.294
-0.1%
|
6,28
|
20.686 USD
|
|
|
2024-10-18 |
2024-10-16 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
6.900
-0.1%
6,57
45.336 USD
|
6.900
-0.1%
|
6,57
|
45.336 USD
|
|
|
2024-10-18 |
2024-10-15 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
4.017
-0.1%
6,50
26.098 USD
|
4.017
-0.1%
|
6,50
|
26.098 USD
|
|
|
2024-10-18 |
2024-10-14 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
4.031
-0.1%
6,54
26.360 USD
|
4.031
-0.1%
|
6,54
|
26.360 USD
|
|
|
2024-10-18 |
2024-10-11 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
2.572
-0.0%
6,35
16.320 USD
|
2.572
-0.0%
|
6,35
|
16.320 USD
|
|
|
2024-10-18 |
2024-10-10 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
2.504
-0.0%
6,12
15.317 USD
|
2.504
-0.0%
|
6,12
|
15.317 USD
|
|
|
2024-10-18 |
2024-10-09 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
3.123
-0.1%
6,10
19.065 USD
|
3.123
-0.1%
|
6,10
|
19.065 USD
|
|
|
2024-10-18 |
2024-10-08 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
6.000
-0.1%
6,43
38.552 USD
|
6.000
-0.1%
|
6,43
|
38.552 USD
|
|
|
2024-10-18 |
2024-10-07 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
4.910
-0.1%
6,66
32.687 USD
|
4.910
-0.1%
|
6,66
|
32.687 USD
|
|
|
2024-10-18 |
2024-10-04 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
5.757
-0.1%
6,92
39.830 USD
|
5.757
-0.1%
|
6,92
|
39.830 USD
|
|
|
2024-10-18 |
2024-10-03 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
3.318
-0.1%
6,97
23.115 USD
|
3.318
-0.1%
|
6,97
|
23.115 USD
|
|
|
2024-10-03 |
2024-10-02 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
3.843
-0.1%
6,87
26.401 USD
|
3.843
-0.1%
|
6,87
|
26.401 USD
|
|
|
2024-10-03 |
2024-10-01 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
4.882
-0.1%
6,77
33.051 USD
|
4.882
-0.1%
|
6,77
|
33.051 USD
|
|
|
2024-10-03 |
2024-09-30 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
4.749
-0.1%
6,73
31.961 USD
|
4.749
-0.1%
|
6,73
|
31.961 USD
|
|
|
2024-10-03 |
2024-09-27 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
5.059
-0.1%
6,63
33.541 USD
|
5.059
-0.1%
|
6,63
|
33.541 USD
|
|
|
2024-10-03 |
2024-09-26 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
5.821
-0.1%
6,62
38.535 USD
|
5.821
-0.1%
|
6,62
|
38.535 USD
|
|
|
2024-10-03 |
2024-09-25 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
5.858
-0.1%
6,60
38.663 USD
|
5.858
-0.1%
|
6,60
|
38.663 USD
|
|
|
2024-10-03 |
2024-09-23 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
282
-0.0%
7,54
2.126 USD
|
282
-0.0%
|
7,54
|
2.126 USD
|
|
|
2024-10-03 |
2024-09-20 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
765
-0.0%
7,50
5.738 USD
|
765
-0.0%
|
7,50
|
5.738 USD
|
|
|
2024-10-03 |
2024-09-13 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
1.993
-0.0%
7,59
15.127 USD
|
1.993
-0.0%
|
7,59
|
15.127 USD
|
|
|
2024-10-03 |
2024-09-06 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
11
-0.0%
7,50
83 USD
|
11
-0.0%
|
7,50
|
83 USD
|
|
|
2024-10-03 |
2024-09-04 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
14
-0.0%
7,50
105 USD
|
14
-0.0%
|
7,50
|
105 USD
|
|
|
2024-10-03 |
2024-09-03 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
2.093
-0.0%
7,60
15.907 USD
|
2.093
-0.0%
|
7,60
|
15.907 USD
|
|
|
2024-10-03 |
2024-08-30 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
4.314
-0.1%
7,76
33.477 USD
|
4.314
-0.1%
|
7,76
|
33.477 USD
|
|
|
2024-05-03 |
2024-05-03 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
4.674
-0.1%
14,03
65.576 USD
|
4.674
-0.1%
|
14,03
|
65.576 USD
|
|
|
2024-05-03 |
2024-05-02 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
8.842
-0.3%
14,01
123.876 USD
|
8.842
-0.3%
|
14,01
|
123.876 USD
|
|
|
2024-05-03 |
2024-05-01 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
15.690
-0.5%
14,02
219.974 USD
|
15.690
-0.5%
|
14,02
|
219.974 USD
|
|
|
2024-04-26 |
2024-04-24 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
1.781
-0.1%
14,06
25.041 USD
|
1.781
-0.1%
|
14,06
|
25.041 USD
|
|
|
2024-04-23 |
2024-04-23 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
21.791
-0.6%
14,29
311.393 USD
|
21.791
-0.6%
|
14,29
|
311.393 USD
|
|
|
2024-04-23 |
2024-04-22 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
24.609
-0.7%
14,05
345.756 USD
|
24.609
-0.7%
|
14,05
|
345.756 USD
|
|
|
2024-04-23 |
2024-04-19 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
18.253
-0.5%
14,02
255.907 USD
|
18.253
-0.5%
|
14,02
|
255.907 USD
|
|
|
2024-04-18 |
2024-04-18 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
2.623
-0.1%
14,06
36.879 USD
|
2.623
-0.1%
|
14,06
|
36.879 USD
|
|
|
2024-04-18 |
2024-04-17 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
300
-0.0%
14,15
4.245 USD
|
300
-0.0%
|
14,15
|
4.245 USD
|
|
|
2024-04-18 |
2024-04-16 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
14.069
-0.4%
14,01
197.107 USD
|
14.069
-0.4%
|
14,01
|
197.107 USD
|
|
|
2024-04-15 |
2024-04-12 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
23.101
-0.7%
14,42
333.116 USD
|
23.101
-0.7%
|
14,42
|
333.116 USD
|
|
|
2024-04-15 |
2024-04-11 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
461.899
-11.5%
14,49
6.692.917 USD
|
461.899
-11.5%
|
14,49
|
6.692.917 USD
|
|
|
2024-02-06 |
2024-02-05 |
GV
Geplanter Verkauf
|
Morrell Martha
Chief Medical Officer
Führungsperson
|
3.446
-4.2%
15,17
52.278 USD
|
3.446
-4.2%
|
15,17
|
52.278 USD
|
|
|
2024-02-06 |
2024-02-02 |
GV
Geplanter Verkauf
|
Morrell Martha
Chief Medical Officer
Führungsperson
|
14.143
-14.8%
15,07
213.122 USD
|
14.143
-14.8%
|
15,07
|
213.122 USD
|
|
|
2024-02-01 |
2024-02-01 |
GV
Geplanter Verkauf
|
Morrell Martha
Chief Medical Officer
Führungsperson
|
663
-0.7%
15,04
9.971 USD
|
663
-0.7%
|
15,04
|
9.971 USD
|
|
|
2024-02-01 |
2024-01-31 |
GV
Geplanter Verkauf
|
Morrell Martha
Chief Medical Officer
Führungsperson
|
1.923
-2.0%
15,08
28.990 USD
|
1.923
-2.0%
|
15,08
|
28.990 USD
|
|
|
2024-02-01 |
2024-01-30 |
GV
Geplanter Verkauf
|
Morrell Martha
Chief Medical Officer
Führungsperson
|
11.262
-10.3%
15,10
170.004 USD
|
11.262
-10.3%
|
15,10
|
170.004 USD
|
|
|
2024-01-26 |
2024-01-25 |
GV
Geplanter Verkauf
|
Morrell Martha
Chief Medical Officer
Führungsperson
|
1
-0.0%
15,00
15 USD
|
1
-0.0%
|
15,00
|
15 USD
|
|
|
2024-01-26 |
2024-01-24 |
GV
Geplanter Verkauf
|
Morrell Martha
Chief Medical Officer
Führungsperson
|
827
-0.8%
15,03
12.426 USD
|
827
-0.8%
|
15,03
|
12.426 USD
|
|
|
2023-12-28 |
2023-12-27 |
GV
Geplanter Verkauf
|
Morrell Martha
Chief Medical Officer
Führungsperson
|
13.300
-10.8%
10,12
134.648 USD
|
13.300
-10.8%
|
10,12
|
134.648 USD
|
|
|
2023-12-28 |
2023-12-26 |
GV
Geplanter Verkauf
|
Morrell Martha
Chief Medical Officer
Führungsperson
|
102
-0.1%
10,00
1.020 USD
|
102
-0.1%
|
10,00
|
1.020 USD
|
|
|
2023-12-22 |
2023-12-20 |
GV
Geplanter Verkauf
|
Morrell Martha
Chief Medical Officer
Führungsperson
|
2.730
-2.2%
10,14
27.695 USD
|
2.730
-2.2%
|
10,14
|
27.695 USD
|
|
|
2023-12-07 |
2023-12-06 |
GV
Geplanter Verkauf
|
Morrell Martha
Chief Medical Officer
Führungsperson
|
11.005
-8.0%
8,16
89.773 USD
|
11.005
-8.0%
|
8,16
|
89.773 USD
|
|
|
2023-12-01 |
2023-12-01 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
3.241
-0.1%
8,73
28.294 USD
|
3.241
-0.1%
|
8,73
|
28.294 USD
|
|
|
2023-12-01 |
2023-11-30 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
7.282
-0.1%
8,84
64.373 USD
|
7.282
-0.1%
|
8,84
|
64.373 USD
|
|
|
2023-12-01 |
2023-11-29 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
5.644
-0.1%
8,72
49.216 USD
|
5.644
-0.1%
|
8,72
|
49.216 USD
|
|
|
2023-11-29 |
2023-11-28 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
4.681
-0.1%
8,75
40.959 USD
|
4.681
-0.1%
|
8,75
|
40.959 USD
|
|
|
2023-11-29 |
2023-11-27 |
V
Verkauf
|
KCK LTD.
Large shareholder
|
6.490
-0.1%
8,96
58.150 USD
|
6.490
-0.1%
|
8,96
|
58.150 USD
|
|
|
2023-10-04 |
2023-10-03 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
700
-0.0%
9,02
6.314 USD
|
700
-0.0%
|
9,02
|
6.314 USD
|
|
|
2023-10-04 |
2023-10-02 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
7.614
-0.2%
9,08
69.135 USD
|
7.614
-0.2%
|
9,08
|
69.135 USD
|
|
|
2022-11-23 |
2022-11-22 |
K
Kauf
|
Accelmed Partners II L.P.
Large shareholder
|
62.398
+1.4%
1,50
93.535 USD
|
62.398
+1.4%
|
1,50
|
93.535 USD
|
|
|
2022-11-23 |
2022-11-21 |
K
Kauf
|
Accelmed Partners II L.P.
Large shareholder
|
327.893
+8.1%
1,50
491.512 USD
|
327.893
+8.1%
|
1,50
|
491.512 USD
|
|
|
2022-06-09 |
2022-06-08 |
GV
Geplanter Verkauf
|
Ridley Irina
General Counsel and Secretary
Führungsperson
|
2.500
-3.9%
5,78
14.445 USD
|
2.500
-3.9%
|
5,78
|
14.445 USD
|
|
|
2022-03-01 |
2022-02-28 |
GV
Geplanter Verkauf
|
Ridley Irina
General Counsel and Secretary
Führungsperson
|
1.470
-18.1%
7,54
11.082 USD
|
1.470
-18.1%
|
7,54
|
11.082 USD
|
|
|
2021-04-23 |
2021-04-21 |
K
Kauf
|
Norton Evan
Nicht geschäftsführender Verwaltungsratsmitglied
|
588.235
+inf%
17,00
9.999.995 USD
|
588.235
+inf%
|
17,00
|
9.999.995 USD
|
|
|
2021-04-23 |
2021-04-21 |
K
Kauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
235.000
+inf%
17,00
3.995.000 USD
|
235.000
+inf%
|
17,00
|
3.995.000 USD
|
|
|
2021-04-23 |
2021-04-21 |
K
Kauf
|
Accelmed Partners II L.P.
Large shareholder
|
588.235
+inf%
17,00
9.999.995 USD
|
588.235
+inf%
|
17,00
|
9.999.995 USD
|
|
|
2021-04-23 |
2021-04-21 |
K
Kauf
|
Fischer Frank M
Nicht geschäftsführender Verwaltungsratsmitglied
|
50.000
+115.5%
17,00
850.000 USD
|
50.000
+115.5%
|
17,00
|
850.000 USD
|
|
|
2021-04-23 |
2021-04-21 |
K
Kauf
|
Garfield Greg Shaw
Nicht geschäftsführender Verwaltungsratsmitglied
|
13.235
+51.7%
17,00
224.995 USD
|
13.235
+51.7%
|
17,00
|
224.995 USD
|
|
|
2021-04-23 |
2021-04-21 |
K
Kauf
|
Ridley Irina
General Counsel and Secretary
Führungsperson
|
2.352
+inf%
17,00
39.984 USD
|
2.352
+inf%
|
17,00
|
39.984 USD
|
|
